In the News
HMI Medical collaborates with Singlife & Novo Nordisk on Singapore’s First Insurer-led Chronic Care Programme for Weight Management
In a landmark move bridging insurance, pharmaceuticals, and clinical care, Singlife, Novo Nordisk Singapore, and HMI Medical has launched Singapore’s first insurer-led chronic care programme for weight management. This groundbreaking initiative provides eligible policyholders with structured, doctor-led medical support: pioneering a proactive model to tackle chronic obesity and improve long-term health outcomes in Singapore.
15 October 2026
Share
HMI Medical is proud to collaborate with Singlife and Novo Nordisk Singapore on the launch of Singapore’s first insurer-led chronic care programme for weight management.
Addressing the critical need for proactive health solutions, the landmark initiative connects patients with structured, doctor-led medical care across HMI Medical's network.
This partnership helps address those barriers by making structured, evidence-based care easier to access through more than 25 clinics islandwide and telemedicine, while supporting patients with appropriate treatment over time and helping them better manage related metabolic risks such as diabetes, hypertension and cardiovascular conditions.
Dr Walter Lim, Chief Executive Officer, HMI Singapore
By shifting the healthcare model from reactive treatment to integrated, long-term disease management, the programme empowers patients with the clinical guidance and sustainable tools required to achieve lasting health outcomes.